ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.802,06
-0,19%
S&P 500
5.291,34
0,15%
US Dollar vs BRL
5,2892
0,74%
Bitcoin
70.507,50
2,48%
Brent Oil
77,11
-1,32%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Glaukos Corporation (GKOS)

  7. Glaukos Corporation (GKOS) Notícias

GKOS

Glaukos (GKOS)

Glaukos Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:GKOS
DataHoraFonteTítuloCódigoCompanhia
03/06/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
03/06/202417:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
30/05/202417:45Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:GKOSGlaukos Corporation
28/05/202408:00Business WireGlaukos Announces Participation in Upcoming Investor ConferencesNYSE:GKOSGlaukos Corporation
20/05/202408:00Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
01/05/202417:05Business WireGlaukos Announces First Quarter 2024 Financial ResultsNYSE:GKOSGlaukos Corporation
16/04/202417:05Business WireGlaukos Announces the Release of its 2023 Sustainability ReportNYSE:GKOSGlaukos Corporation
10/04/202408:00Business WireGlaukos to Release First Quarter 2024 Financial Results after Market Close on May 1NYSE:GKOSGlaukos Corporation
03/04/202408:00Business WireGlaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)NYSE:GKOSGlaukos Corporation
01/04/202408:00Business WireGlaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual MeetingNYSE:GKOSGlaukos Corporation
04/03/202422:07Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:GKOSGlaukos Corporation
23/02/202419:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:GKOSGlaukos Corporation
21/02/202418:05Business WireGlaukos Announces Fourth Quarter and Full Year 2023 Financial ResultsNYSE:GKOSGlaukos Corporation
13/02/202419:41Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:GKOSGlaukos Corporation
31/01/202409:00Business WireGlaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21NYSE:GKOSGlaukos Corporation
09/01/202409:00Business WireGlaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue GuidanceNYSE:GKOSGlaukos Corporation
20/12/202309:00Business WireGlaukos Announces Participation in the J.P. Morgan Healthcare ConferenceNYSE:GKOSGlaukos Corporation
14/12/202310:04Dow Jones NewsFDA Approves Glaukos' New Drug Application for iDose TRNYSE:GKOSGlaukos Corporation
14/12/202309:00Business WireGlaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)NYSE:GKOSGlaukos Corporation
07/11/202309:00Business WireGlaukos Announces Participation in Stifel Healthcare ConferenceNYSE:GKOSGlaukos Corporation
01/11/202317:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:GKOSGlaukos Corporation
01/11/202317:05Business WireGlaukos Announces Third Quarter 2023 Financial ResultsNYSE:GKOSGlaukos Corporation
31/10/202308:00Business WireGlaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual MeetingNYSE:GKOSGlaukos Corporation
11/10/202308:00Business WireGlaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023NYSE:GKOSGlaukos Corporation
23/08/202308:00Business WireGlaukos Announces Participation in Wells Fargo Healthcare ConferenceNYSE:GKOSGlaukos Corporation
02/08/202317:05Business WireGlaukos Announces Second Quarter 2023 Financial ResultsNYSE:GKOSGlaukos Corporation
17/07/202308:00Business WireGlaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.NYSE:GKOSGlaukos Corporation
12/07/202308:00Business WireGlaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023NYSE:GKOSGlaukos Corporation
28/06/202317:21Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NYSE:GKOSGlaukos Corporation
12/06/202318:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:GKOSGlaukos Corporation
 Apresentando as notícias mais relevantes sobre:NYSE:GKOS

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
GFSA3
GAFISA ON
BOV
AZEV4
AZEVEDO PN
BOV
AMER3
Americanas ON
BOV
OIBR3
OI ON
BOV
RCSL3
RECRUSUL ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
COGN3
COGNA ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
MEAL3
IMC S/A ON
BOV
CEAB3
C&A ON
BOV
HAGA3
HAGA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados